Michigan receives approval to implement outcomes-based drug contracts in Medicaid; in the first 10 days since open enrollment began, 1.2 million people have signed up for Affordable Care Act health plans, which falls short of the 1.5 million people who signed up in the first 9 days last year; new research has found that in states with lax gunshot laws, children are twice as likely to die from gunshot wounds compared with states with stricter laws.
CMS has approved Michigan’s waiver to save money in the Medicaid program by using an outcomes-based approach for drug contracts. The Associated Press reported that the state’s plan addresses the impact of new, expensive therapies. If a medicine does not perform as promised, drug manufacturers would provide increased supplemental rebate payments to Michigan’s Medicaid program. A similar proposal had been approved in Oklahoma in June.
Early enrollment numbers have shown that 1.2 million people have signed up for Affordable Care Act health plans in the first 10 days since open enrollment, which falls short of the 1.5 million people who signed up in the first 9 days last year, according to The Hill. However, Larry Levitt, with the Kaiser Family Foundation, noted that it is still too soon to tell what may have caused the drop and signups are likely to surge as the deadline approaches. One factor that could have affected signups could have been the election this year, which may have diverted attention from enrollment. Open enrollment ends on December 15.
New research presented at the American Academy of Pediatrics has found that in states with lax gunshot laws, children are twice as likely to die from gunshot wounds compared with states with stricter laws. According to Reuters, the researchers adjusted for factors such as family poverty, unemployment, and substance abuse, which could influence the risk of gun-related death. States with the weakest gun laws had 5 child deaths by gunshot per 100,000 compared with 2.56 child deaths in states with the strongest laws.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen